Delivery of integrated infectious disease control services under the new antenatal care guidelines: a service availability and readiness assessment of health facilities in Tanzania

Odjidja, Emmanuel Nene; Gatasi, Ghislaine; Đurić, Predrag

doi:10.1186/s12913-019-3990-8

Cited by 12 publications

(13 citation statements)

References 12 publications

(13 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…9 For TB diagnostics, the Xpert XVI (64 tests/8 hours; Cepheid) and the Xpert Infinity-80 (320 tests/8 hours; Cepheid) systems are used. 10 In response to the need for HIV and TB integration of care 11 and to address gaps in access to pathology and laboratory health services in low-resource settings, 12 manufacturing companies are increasing the number and types of diagnostic tests available on molecular diagnostic platforms. 9,10,13,14 Following this approach, the cobas MTB assay was developed for integration on to the fully automated, high-throughput cobas 6800/8800 system, which was initially only used for HIV viral load monitoring.…”

mentioning

confidence: 99%

Performance of the Roche cobas MTB Assay for the Molecular Diagnosis of Pulmonary Tuberculosis in a High HIV Burden Setting

Scott

David

Govender

et al. 2020

The Journal of Molecular Diagnostics

View full text Add to dashboard Cite

show abstract

mentioning

confidence: 99%

Performance of the Roche cobas MTB Assay for the Molecular Diagnosis of Pulmonary Tuberculosis in a High HIV Burden Setting

Scott

David

Govender

et al. 2020

The Journal of Molecular Diagnostics

View full text Add to dashboard Cite

show abstract

“…In addition to integrated care—which studies show is still a long way from being available to pregnant women with infectious diseases [ 40 ]—the results of this study show that besides additional psychosocial and socioeconomic support pregnant women with RR-TB would benefit from tailored counseling aimed at addressing their specific needs in both the ante- and post-partum periods. Such counseling, could include how health care providers best communicate with pregnant women, understanding their rights around delivery, and how to manage common adverse events.…”

Section: Discussionmentioning

confidence: 99%

“Take the treatment and be brave”: Care experiences of pregnant women with rifampicin-resistant tuberculosis

2020

View full text Add to dashboard Cite

Background There are few data on the on the care experiences of pregnant women with rifampicin-resistant TB. Objective To describe the treatment journeys of pregnant women with RR-TB—including how their care experiences shape their identities—and identify areas in which tailored interventions are needed. Methods In this qualitative study in-depth interviews were conducted among a convenience sample from a population of pregnant women receiving treatment for RR-TB. This paper follows COREQ guidelines. A thematic network analysis using an inductive approach was performed to analyze the interview transcripts and notes. The analysis was iterative and a coding system developed which focused on the care experiences of the women and how these experiences affected their perceptions of themselves, their children, and the health care system in which treatment was received. Results Seventeen women were interviewed. The women described multiple challenges in their treatment journeys which required them to demonstrate sustained resilience (i.e. to “be brave”). Care experiences required them to negotiate seemingly contradictory identities as both new mothers—“givers of life”—and RR-TB patients facing a complicated and potentially deadly disease. In terms of their “pregnancy identity” and “RR-TB patient identity” that emerged as part of their care experiences, four key themes were identified that appeared to have elements that were contradictory to one another (contradictory areas). These included: 1) the experience of physical symptoms or changes; 2) the experience of the “mothering” and “patient” roles; 3) the experience of the care they received for their pregnancy and their RR-TB; and 4) the experience of community engagement. There were also three areas that overlapped with both roles and during which identity was negotiated/reinforced and they included: 1) faith; 2) socioeconomic issues; and 3) long-term concerns over the child’s health. At times, the health care system exacerbated these challenges as the women were not given the support they needed by health care providers who were ill-informed or angry and treated the women in a discriminatory fashion. Left to negotiate this confusing time period, the women turned to faith, their own mothers, and the fathers of their unborn children. Conclusion The care experiences of the women who participated in this study highlight several gaps in the current health care system that must be better addressed in both TB and perinatal services in order to improve the therapeutic journeys for pregnant women with RR-TB and their children. Suggestions for optimizing care include the provision of integrated services, including specialized counseling as well as training for health care providers; engagement of peer support networks; provision of socioeconomic support; long-term medical care/follow-up for children born to women who were treated for RR-TB; and inclusion of faith-based services in the provision of care.

show abstract

“…However, 8,600 children still acquired HIV in 2018 (Ministry of Health, 2017a). Odjidja, et al (2019) conclude that the integration of health services can be an effective mechanism to increase coverage and to reduce the impact of infectious diseases during pregnancy. The authors found that the strongest determinant of receiving integrated care during antenatal session was having a trained staff in all disease areas on site.…”

Section: Self Testingmentioning

confidence: 92%

“…To reach as many women as possible, the vast majority of PMTCT services are now integrated with reproductive and child health services (Ministry of Health, 2013a). Odjidja et al (2019) report that Tanzania has adopted WHO's latest antenatal care (ANC) guidelines which recommend comprehensive services including diagnostic screening and treatment for pregnant women during antenatal care. Such provision visits purportedly increase the HIV testing rate among mothers age and enrolment in paediatric ART (Bergmann et al, 2017).…”

Section: Self Testingmentioning

confidence: 99%

See 1 more Smart Citation

Malaria, HIV and TB in Tanzania: Epidemiology, Disease Control Challenges and Interventions

Avis¹

2022

View full text Add to dashboard Cite

Tanzania, officially the United Republic of Tanzania, is a country in East Africa within the African Great Lakes region. The population is estimated to be 61 million in 2021. Malaria, HIV and tuberculosis (TB) are significant public health concerns in Tanzania. HIV/AIDS was the third leading cause of death in the country in 2019 (Global Burden of Disease, 2021), accounting for 27,000 deaths in 2020 (UNAIDS, 2020). Tanzania is among the ten countries with the highest malaria cases and deaths (3% of the global cases, 13.4% of cases in East and Southern Africa, and 5% of global deaths) (Severe Malaria Observatory, 2021). Tanzania is one of the High TB Burden Countries, and one of the High TB/HIV Burden Countries. In Tanzania, it is estimated that of 154,000 new cases of TB in 2017, 31% (48,000) were also HIV positive (WHO, 2018). TB has been the leading cause of death among HIV positive individuals (Mollel et al., 2019), a close monitoring of its occurrence in this subgroup of people is important. This rapid literature review highlights key aspects of the epidemiology of malaria, HIV and TB in Tanzania and challenges in prevention, detection and treatment; and surveys select interventions that seek to address these challenges. This is part of a series of reports looking into Epidemiology of Malaria, human immune deficiency virus (HIV) and tuberculosis (TB) across a set of African Nations.

show abstract

Delivery of integrated infectious disease control services under the new antenatal care guidelines: a service availability and readiness assessment of health facilities in Tanzania

Cited by 12 publications

References 12 publications

Performance of the Roche cobas MTB Assay for the Molecular Diagnosis of Pulmonary Tuberculosis in a High HIV Burden Setting

Performance of the Roche cobas MTB Assay for the Molecular Diagnosis of Pulmonary Tuberculosis in a High HIV Burden Setting

“Take the treatment and be brave”: Care experiences of pregnant women with rifampicin-resistant tuberculosis

Malaria, HIV and TB in Tanzania: Epidemiology, Disease Control Challenges and Interventions

Contact Info

Product

Resources

About